4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001642247-17-000020
Director bought 30,000 shares at an average $0.44 ($13,236)
From the SEC's structured data for this filing
Trades in this filing
Vitale Philip J · Director
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-16 | Purchase : show line 1 in the form | +100 | $0.43 | $43 | 40,100 | D |
| 2017-11-16 | Purchase : show line 2 in the form | +100 | $0.43 | $43 | 40,200 | D |
| 2017-11-16 | Purchase : show line 3 in the form | +8,480 | $0.43 | $3,646 | 48,680 | D |
| 2017-11-16 | Purchase : show line 4 in the form | +200 | $0.43 | $86 | 48,880 | D |
| 2017-11-16 | Purchase : show line 5 in the form | +400 | $0.44 | $176 | 49,280 | D |
| 2017-11-16 | Purchase : show line 6 in the form | +3,049 | $0.44 | $1,335 | 52,329 | D |
| 2017-11-16 | Purchase : show line 7 in the form | +18 | $0.44 | $8 | 52,347 | D |
| 2017-11-16 | Purchase : show line 8 in the form | +1,400 | $0.44 | $615 | 53,747 | D |
| Open-market purchases · 30,000 sh · avg $0.44 · $13,236 | ||||||
Loading xslF345X03/primary_doc.xml…